TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

LogicBio Therapeutics, Inc. (NASDAQ: LOGC) Investor Securities Class Action Lawsuit 03/19/2020

  • If you purchased shares of LogicBio Therapeutics, Inc. (NASDAQ: LOGC), you may have certain options. Please contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

June 2, 2020 - The case was transferred to the U.S. District Court for the District of Massachusetts. March 18, 2020 - An investor in shares of LogicBio Therapeutics, Inc. (NASDAQ: LOGC) filed a lawsuit in the U.S. District Court for the District of New Jersey over alleged violations of Federal Securities Laws by LogicBio Therapeutics, Inc. in connection with certain allegedly false ...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)

@screen width:
@theme:
@breakpoints:
@layout: